ArticleFrontiers in oncology2025

PITX1 as a grading, prognostic and tumor-infiltrating immune cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis.

Zikun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.